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Retinitis pigmentosa (RP, OMIM 268000) represents 
a clinically heterogeneous group of progressive inherited 
retinal disorders that primarily affect rod photoreceptor cells, 
followed by secondary cone photoreceptor cell degeneration 
[1-3]. RP is the most frequent cause of inherited blindness, 
affecting approximately 1 in 3,500 to 1 in 5,000 people world-
wide. This disease is initially characterized by night blind-
ness followed by visual field constriction that can ultimately 
lead to legal blindness at a later stage [4].
In addition to the clinical diversity of RP, the disease 
is genetically heterogeneous. RP can be inherited in an 
autosomal dominant (adRP, 30% to 40%), autosomal reces-
sive (arRP, 50% to 60%, with sporadic cases accounting for 
about 45% of all RP [4]), or X-linked (xlRP, 5% to 20%) 
[1,4], and rarely in a digenic manner [3,5]. At present, of 55 
genes known to be mutated in individuals with RP, most 
display allelic heterogeneity, and some have been implicated 
in both dominant and recessive modes of inheritance e.g., 
bestrophin 1 (BEST1), neural retina leucine zipper (NRL), 
nuclear receptor subfamily 2, group E, member 3 (NR2E3), 
rhodopsin (RHO), retinitis pigmentosa 1 (RP1), and retinal 
pigment epithelium-specific protein 65 kDa (RPE65); RetNet-
Retinal Information Network; provided in the public domain 
by the University of Texas Houston Health Science Center, 
Houston, TX).
Mutations in the retinitis pigmentosa 1 gene (RP1, 
OMIM 603937) are thought to account for approximately 
5.5% of adRP cases and only 1% of arRP cases, depending 
on the type and the position of the mutations [6]. To date, 
more than 50 disease-causing mutations in the RP1 gene 
have been identified. They are predominantly frameshift 
or nonsense mutations in individuals with dominant RP, 
clustered in a region spanning codons 500–1053 in exon 4 
[6-24]. Only a few cases of recessive RP1 mutations in exon 
4 have been reported [6,20,25-29], the majority of which is 
located very close to the 3′ end of exon 4. Here, we report an 
early truncating mutation in the 5′ part of exon 4 (c.1012C>T; 
p.R338*), which we found was homozygously present in an 
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Purpose: The purpose of this study was to identify the underlying molecular genetic defect in an Indonesian family with 
three affected individuals who had received a diagnosis of retinitis pigmentosa (RP).
Methods: Clinical evaluation of the family members included measuring visual acuity and fundoscopy, and assessing 
visual field and color vision. Genomic DNA of the three affected individuals was analyzed with Illumina 700k single 
nucleotide polymorphism (SNP) arrays, and homozygous regions were identified using PLINK software. Mutation analy-
sis was performed with sequence analysis of the retinitis pigmentosa 1 (RP1) gene that resided in one of the homozygous 
regions. The frequency of the identified mutation in the Indonesian population was determined with TaqI restriction 
fragment length polymorphism analysis.
Results: A novel homozygous nonsense mutation in exon 4 of the RP1 gene, c.1012C>T (p.R338*), was identified in the 
proband and her two affected sisters. Unaffected family members either carried two wild-type alleles or were heterozy-
gous carriers of the mutation. The mutation was not present in 184 Indonesian control samples.
Conclusions: Most of the previously reported RP1 mutations are inherited in an autosomal dominant mode, and appear 
to cluster in exon 4. Here, we identified a novel homozygous p.R338* mutation in exon 4 of RP1, and speculate on the 
mutational mechanisms of different RP1 mutations underlying dominant and recessive RP.
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Indonesian family segregating arRP. A heterozygous carrier 
of this nonsense mutation did not display any clinical abnor-
malities characteristic of RP. Therefore, our findings suggest 
that this particular null allele of RP1 causes recessive rather 
than dominant RP.
METHODS
Subjects: An Indonesian family of Javanese origin with 
three affected individuals and two available unaffected rela-
tives was included in this study (Figure 1). Affected family 
members were diagnosed by an ophthalmologist at the Dr. 
Kariadi Hospital in Semarang, Central Java, Indonesia. 
This study was approved by the ethical review boards of the 
centers involved. Informed consent adhering to the tenets of 
the Declaration of Helsinki was obtained from all partici-
pating affected individuals and unaffected family members. 
In addition, 184 ethnically matched and unrelated control 
individuals took part in this study.
Clinical characterization: The three affected individuals 
(II:4, II:6, and II:7) and two unaffected relatives (I:1 and 
II:2) underwent a detailed ophthalmologic examination that 
included evaluation of visual acuity measurement, fundos-
copy, and fundus photography after pupillary dilation. Color 
vision was tested using Ishihara plates. The size and extent 
of the visual field defects were assessed with a Humphrey 
Visual Field Analyzer (Carl Zeiss Meditec, Dublin, CA). 
Fundus photographs were taken using a Visucam Pro NM 
(Carl Zeiss Meditec).
Homozygosity mapping: EDTA blood samples were obtained 
from all participants. Total genomic DNA was extracted from 
peripheral leukocytes using a standard salting out procedure 
[30]. DNA aliquots of each individual were stored at −20 °C. 
Affected individuals were genotyped on Infinium Human 
OmniExpress 700 K arrays (Illumina, San Diego, CA) 
containing approximately 700,000 single nucleotide polymor-
phisms (SNPs). Array experiments were performed according 
to the protocol provided by the manufacturer. Homozygous 
regions were determined using PLINK software [31], with 
parameters manually set at a cut-off of 1 Mb, and allowing 
two heterozygous SNPs and ten missing SNPs per window 
of 50 SNPs.
Homozygous regions were ranked based on the size of 
the regions. The SNP positions were derived from the UCSC 
Human Genome Browser build NCBI36/hg18, March 2006.
Mutation analysis: Primers for RP1 were designed 
using Primer3 software [32] and are listed in Table 1. All 
coding exons and exon-intron boundaries of the RP1 gene 
(NM_006269) were amplified with touch-down polymerase 
chain reaction (PCR) from 50 ng of genomic DNA. PCR reac-
tions were performed in a volume of 25 µl containing 50 ng 
genomic DNA, 0.2 µM of each primer, 2 mM MgCl2, 1 mM 
deoxyribonucleotide triphosphates, PCR buffer provided 
by the manufacturer, and 0.5 U Taq polymerase (cat. no. 
18,038–042; Invitrogen, Breda, The Netherlands).
PCR products were purified on NucleoSpin Plasmid 
QuickPure columns (Macherey-Nagel GmbH & Co, Duren, 
Germany) and analyzed either in the sense or antisense direc-
tion using dye termination chemistry (BigDye Terminator 
Cycle Sequencing Kit version 3.1; on a 3130 DNA automated 
sequencer; Applied Biosystems, Foster City, CA). Segregation 
Figure 1. Pedigree structure and 
mutation analysis of the Indone-
sian arRP family. A: In the family 
pedigree, affected individuals 
are indicated with filled symbols 
whereas unaffected relatives are 
indicated with open symbols. 
Genotypes are indicated below the 
pedigree symbols. M represents the 
c.1012C>T: (p.R338*) substitution, 
and + represents the wild-type 
allele. B: Shown are sequence chro-
matograms of RP1 corresponding 
to the three affected individuals (II:4, II:6, II:7), the proband’s father I:1), and one unaffected sibling (II:2). The substituted nucleotides are 
indicated with arrows.
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analysis of the RP1 mutation identified in the family was 
performed with sequence analysis. The frequency of this 
mutation in 184 unrelated and unaffected ethnically matched 
Indonesian controls was assessed by digesting PCR products 
with TaqI (New England Biolabs, Ipswich, MA), the recogni-
tion site of which is abolished by the alteration in RP1.
RESULTS AND DISCUSSION
All three affected individuals (II:4, II:6, and II:7) presented 
with night blindness that started at an early age. They 
displayed gradual constriction of their visual field and 
low visual acuity. Fundus examination revealed typical 
RP including the bone spicule-like pigment deposits in the 
mid-peripheral retina and narrowing of the retinal vessels 
(Figure 2). The unaffected sibling (II:2) did not experi-
ence night blindness or any other symptoms of RP. Apart 
from slightly decreased visual acuity, which is probably 
age-related, the proband’s father (I:1) did not display any 
ophthalmological symptoms either. The clinical data for all 
participating individuals are summarized in Table 2.
Genome-wide SNP array analysis revealed four homo-
zygous regions larger than 1 Mb that were shared among 
the three affected siblings (Table 3). Whereas no obvious 
candidate genes resided in the three largest homozygous 
regions, the fourth largest homozygous region (1.3 Mb, on 
chromosome 8q12.1) encompassed RP1.
Table 1. Primer sequences for The amPlificaTion of The RP1 gene.
Primer Sequence (5′-3′) Product size (base pairs)
RP1 exon1 F CCATGTATTCGCTATGGTGC 421
RP1 exon1 R TGTCCAGGTCTACAGGCTGC
RP1 exon2 F GGCAGGCACAGCATCAC 434
RP1 exon2 R CACCATTCATATCCCACACG
RP1 exon3 F TTCAAGCCTAGGAGGTTGTTG 357
RP1 exon3 R ATTGAAGCATGGATTTTGCC
RP1 exon4_1 F GATATTTCTAACTTCTCTGCCTTCC 595
RP1 exon4_1 R CCCTGGATGATATCTGTGTCC
RP1 exon4_2 F ATCAAGAGGGCAGTTTGGC 592
RP1 exon4_2 R TTGAAGTTCTTGATACCAGTTTTG
RP1 exon4_3 F TCACATAATAATGGTTTGCCATC 599
RP1 exon4_3 R TTTCTATGGAAATTCTTGGAAATC
RP1 exon4_4 F TCCCCTTAAAGGAGGGATAC 580
RP1 exon4_4 R AATTGAATGATGAGCAATAGCC
RP1 exon4_5 F GAATGGCAAAGAAGAGTTTAGTTTC 739
RP1 exon4_5 R ACTGAAGCTTGCAATTGGTG
RP1 exon4_6 F GCTTATTTGGTTCCCCTGC 678
RP1 exon4_6 R AGAGCAACCTCCATCCAAAG
RP1 exon4_7 F ACTTGAAAGCTGCTGTTGCC 659
RP1 exon4_7 R GCTTAAATTACTGACATTTTGATGTG
RP1 exon4_8 F CAATGTCTGCAATACCATTGAC 658
RP1 exon4_8 R TCCTTCATTGGTCTCCTTTTC
RP1 exon4_9 F TTAATCCAAGAAGAGGTAGAGGC 616
RP1 exon4_9 R CCTGGAATTCCTGCAACATAG
RP1 exon4_10 F TGGAATTTCAGTGTTCCAGG 592
RP1 exon4_10 R TGATGACTACCCTTCTCCTCTG
RP1 exon4_11 F CATGGTAGTGACTCAGAACCTTTTC 590
RP1 exon4_11 R CCTTCTTCCTCTAACCCCAAG
RP1 exon4_12 F GATAATGCCATTGGTGATATATTTG 600
RP1 exon4_12 R CGTATTCGTCACATGTGCTTC
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Sequence analysis of RP1 revealed a novel homozygous 
substitution (c.1012C>T) in the proximal portion of exon 
4, replacing an arginine residue at position 338 with a stop 
codon (p.R338*). Sequence chromatograms and segrega-
tion analysis of the RP1 mutation are shown in Figure 1. 
This nonsense alteration was not present in the unaffected 
sibling, and was identified heterozygously in the unaffected 
father, who did not show any symptoms of RP. To rule out 
the possibility that the second allele (inherited from the 
mother) harbors a deletion of RP1 responsible for the loss of 
heterozygosity, we employed copy number analysis of our 
genome-wide SNP data and did not find any abnormalities 
in this genomic region. The mutation was not detected in 184 
ethnically matched and unrelated Indonesian control subjects.
The RP1 gene consists of four exons and gives rise to a 
transcript of approximately 7.1 kb encoding a protein of 2,156 
amino acids. The RP1 protein is localized in the region of the 
Figure 2. Fundus photographs of affected individuals. Fundus photographs of the right eye from affected individual II:4 A: affected indi-
vidual II:6 B: affected individual II:7 C: and the unaffected father I:1 D: who carries the mutation heterozygously. The ages at the time of 
investigation of individuals II:4, II:6, and II:7 were 36, 28, and 26, respectively. Fundus examination of the affected individuals revealed 
typical features of retinitis pigmentosa, bone spicule-like pigmentations were found in the mid periphery of retina (indicated with arrows), 
and retinal vessels were attenuated (arrowheads).
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connecting cilium and axoneme of photoreceptor sensory cilia 
[7]. RP1 is a photoreceptor-specific microtubule-associated 
protein that regulates the length and stability of the photore-
ceptor axoneme mediated by the two putative doublecortin 
domains at the N-terminus of RP1 [33]. The doublecortin 
domain is essential for the correct localization and proper 
stacking of outer segment discs [34-36]. Moreover, a region 
of the RP1 protein between codons 486 and 635 bears some 
homology to the Drosophila melanogaster bifocal protein that 
is required for normal photoreceptor morphogenesis in the 
fruit fly [7].
The many mutations in exon 4 of RP1, which cause 
autosomal dominant RP, all tend to cluster in a “hot spot” 
region between amino acid residues 500 and 1053 (Figure 
Figure 3. RP1 gene and identified mutations. Schematic representation of the location of mutations in the RP1 gene. Below are mutations 
responsible for dominant retinitis pigmentosa (adRP) whereas mutations above the gene cause autosomal recessive RP (arRP). The mutation 
identified in this study is indicated with a black rectangle. The portion of the gene that encodes the doublecortin (DCX) domains (amino 
acids 36–118 and 154–233) is indicated with green, and the Drosophila melanogaster bifocal (BIF) domain (amino acids 486−635) is 
depicted in red. Missense changes, for which the pathogenicity is uncertain, are not included in this scheme. Four groups of arRP-causing 
mutations are marked with numbers. GR.1=protein-truncating mutations that reside in exon 2 or exon 3 (nonsense-mediated mRNA decay); 
GR.2=missense mutations; GR.3=protein-truncating mutations near the 3′ end of the gene, preserving residual activity; GR.4=truncating 
mutations located in the proximal part of exon 4.
Table 2. clinical characTerisTics of ParTiciPaTing family members
Person Current age (y) Gender Age of onset 
(y)
Visual acuity
Fundus appearance
OD OS
II:4 37 F 8 LP+ LP+ AA, BS, POD
II:6 29 F 9 1/300 1/300 AA, BS, POD
II:7 27 F 11 1/300 2/60 AA, BS
I:1 64 M NA 20/40 20/25 Normal
II:2 42 M NA 20/15 20/20 Normal
Clinical characteristics of affected family members carrying two RP1 variants and non-affected family members carrying one RP1 variant 
or two wild-type alleles. Abbreviations: AA: attenuated arterioles; BS: bone spicules; F: female; LP+: light perception; M: male; NA: not 
affected; OD: oculus dexter, right eye; OS: oculus sinister, left eye; POD: pale optic disc.
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3) [6-24]. Since these mutations are expected to be insen-
sitive to nonsense-mediated decay due to the absence of a 
downstream intron, they result in the production of truncated 
proteins [33]. Previously, mutant RP1 mRNA was found to 
be present in a human lymphoblast cell line carrying the 
p.R677* variant, providing evidence that this mRNA indeed 
escapes the nonsense-mediated mRNA decay process. 
The resulting truncated proteins lack important functional 
domains, but are still able to interact with wild-type RP1 and/
or microtubule-associated proteins [35]. This hypothesis is 
supported by a previous study, which showed that in Rp1-myc 
mice that expressed only the 661 N-terminal amino acids of 
RP1, truncated proteins are produced and localize correctly to 
the axonemes of photoreceptor cells [36]. Due to the retained 
ability to interact with microtubule-associated proteins and/or 
wild-type RP1, these mutated proteins are thought to abolish 
the function of the normal RP1 molecules in a dominant-
negative fashion.
For RP1 mutations that cause recessive RP, the story 
is more complex. These mutations can be clustered in four 
different groups (Figure 3). First, protein-truncating muta-
tions that reside in exon 2 or exon 3 are expected to undergo 
nonsense-mediated decay, and therefore can be considered 
true loss-of-function alleles [26,28,29]. The second group 
consists of missense mutations that appear not to cluster 
[25,28]. These changes cause autosomal recessive RP because 
the produced proteins retain residual function and therefore 
are not pathogenic when present in the heterozygous state. 
The third group includes protein-truncating mutations near 
the 3′ end of the gene [6,20,26,27]. Most likely, the resulting 
proteins display only a minor loss of their C-terminal portion, 
preserving the majority of functional domains, and have 
residual activity. Therefore, these variants are also patho-
genic only when present homozygously. Finally, the most 
interesting group of mutations encompasses the few nonsense 
changes located in the proximal part of exon 4 [20,26], and 
includes the mutation identified in this study. Since the 
mRNAs deriving from these alleles are expected to escape 
nonsense-mediated mRNA decay, truncated RP1 proteins 
are likely to be produced. However, unlike the adRP-causing 
proteins, the truncated RP1 proteins apparently lack some 
domains that are crucial for the interactions with wild-type 
RP1 or microtubule-associated proteins, and therefore no 
dominant-negative effect emerges. This is supported by the 
absence of clinical symptoms in the father, who carried the 
p.R338* mutation heterozygously.
Taken together, the results of our study indicate that 
early protein-truncating mutations in RP1, including p.R338*, 
cause autosomal recessive RP, supporting the idea that 
haploinsufficiency is probably not causative for autosomal 
dominant RP. A better understanding of the pathophysiology 
of RP1 mutations may ultimately lead to an improved prog-
nosis, and provide new tools for therapeutic interventions.
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